LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Single-cell profiling of NSCLC tumor treated with Durvalumab and in combination with Tremelimumab.

Photo by nci from unsplash

12104Background: Combination of anti-PD1/L1 and anti-CTLA4 is under investigation for treatment of multiple tumors. However, how this combination modifies the immune micro-environment of tumors is ... Click to show full abstract

12104Background: Combination of anti-PD1/L1 and anti-CTLA4 is under investigation for treatment of multiple tumors. However, how this combination modifies the immune micro-environment of tumors is ...

Keywords: single cell; combination; nsclc tumor; profiling nsclc; tumor treated; cell profiling

Journal Title: Journal of Clinical Oncology
Year Published: 2018

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.